Responding to Macro Trends Disrupting Drug Development
May 8, 2020
•
0 Comment
This session examines trends impacting and transforming drug development performance and economics and discusses how sponsors, CROs and investigative sites are adapting to these trends. Trends examined include digital disruption, emerging new sources of patient data and new clinical trial execution models.